Na skróty
Rozpocznij rozmowę z konsultantem Wyślij swoje pytanie
Money.plGiełda w Money.plKomunikaty ze spółekKomunikaty ze świata
Wiadomości ze spółek na świecie (ang.)
Data Państwo Firma Typ informacji Tytuł
2012-02-22 08:31:00 Sweden Karolinska Development AB (publ) Karolinska Development AB (publ) - Year-End Report 2011 Karolinska Development AB (publ) - Year-End Report 2011
2012-02-21 08:31:00 Sweden Karolinska Development AB (publ) Karolinska Development - Year-End Report, conference call Wednesday, February 22 Karolinska Development - Year-End Report, conference call Wednesday, February 22
2012-02-21 08:01:00 Sweden Karolinska Development AB (publ) Karolinska Development invests in Oss-Q Karolinska Development invests in Oss-Q
2012-02-14 08:02:00 Sweden Karolinska Development AB (publ) KDev Oncology AB invests in GliGene AB KDev Oncology AB invests in GliGene AB
2012-02-13 08:02:00 Sweden Karolinska Development AB (publ) Karolinska Development announces the formation of KDev Oncology AB - Carl Harald Janson appointed as CEO Karolinska Development announces the formation of KDev Oncology AB - Carl Harald Janson appointed as CEO
2012-02-10 07:01:00 Sweden Karolinska Development AB (publ) Pergamum completes patient recruitment to the Phase II clinical trial for prevention of post-surgical adhesions Pergamum completes patient recruitment to the Phase II clinical trial for prevention of post-surgical adhesions
2012-01-16 07:01:00 Sweden Karolinska Development AB (publ) Pergamum initiates Phase II trial with DPK-060 in outer ear infections Pergamum initiates Phase II trial with DPK-060 in outer ear infections
2012-01-09 08:31:00 Sweden Karolinska Development AB (publ) Akinion Pharmaceuticals initiates Phase I/II clinical trial with AKN-028 Akinion Pharmaceuticals initiates Phase I/II clinical trial with AKN-028
2011-12-28 12:16:00 Sweden Karolinska Development AB (publ) Axelar initiates a Phase II clinical study with AXL1717 for the treatment of non-small cell lung cancer Axelar initiates a Phase II clinical study with AXL1717 for the treatment of non-small cell lung cancer
2011-12-12 08:01:00 Sweden Karolinska Development AB (publ) Aprea announces continuation of clinical Phase I/II-study of APR-246 in patients with leukemia Aprea announces continuation of clinical Phase I/II-study of APR-246 in patients with leukemia
2011-11-25 08:31:00 Sweden Karolinska Development AB (publ) Karolinska Development AB (publ) - Interim report January - September 2011 Karolinska Development AB (publ) - Interim report January - September 2011
2011-11-21 10:28:00 Sweden Karolinska Development AB (publ) Karolinska Development - Interim report January - September, conference call Friday, November 25 Karolinska Development - Interim report January - September, conference call Friday, November 25
2011-09-26 14:01:00 Sweden Karolinska Development AB (publ) Axelar reports good safety profile of AXL1717 in Phase I/II in cancer patients - Poster now published on the company's website Axelar reports good safety profile of AXL1717 in Phase I/II in cancer patients - Poster now published on the company's website
2011-09-26 08:31:00 Sweden Karolinska Development AB (publ) Axelar reports good safety profile of AXL1717 in Phase I/II in cancer patients Axelar reports good safety profile of AXL1717 in Phase I/II in cancer patients
2011-09-23 08:31:00 Sweden Karolinska Development AB (publ) Dilaforette initiates a Phase I/II study with Sevuparin for the treatment of severe malaria Dilaforette initiates a Phase I/II study with Sevuparin for the treatment of severe malaria
2011-09-01 08:46:00 Sweden Karolinska Development AB (publ) Michael Sundström appointed as Vice President Discovery Research of Karolinska Development and CEO of Actar Michael Sundström appointed as Vice President Discovery Research of Karolinska Development and CEO of Actar
2011-08-25 08:31:00 Sweden Karolinska Development AB (publ) Karolinska Development AB (publ) - Interim report January - June, 2011 Karolinska Development AB (publ) - Interim report January - June, 2011
2011-08-22 15:38:00 Sweden Karolinska Development AB (publ) Karolinska Development - Interim report January - June, conference call Thursday, August 25 Karolinska Development - Interim report January - June, conference call Thursday, August 25
2011-07-07 09:01:00 Sweden Karolinska Development AB (publ) Axelar reports completion of the Phase I/II safety study with AXL1717 in cancer patients Axelar reports completion of the Phase I/II safety study with AXL1717 in cancer patients
2011-05-26 08:48:00 Sweden Karolinska Development AB (publ) Karolinska Development AB (publ) - Interim report January-March, 2011 Karolinska Development AB (publ) - Interim report January-March, 2011
2011-05-25 11:46:00 Sweden Karolinska Development AB (publ) Resolutions from Karolinska Development's Annual General Meeting Resolutions from Karolinska Development's Annual General Meeting
2011-05-24 09:54:00 Sweden Karolinska Development AB (publ) Karolinska Development - First quarter results conference call Thursday, May 26 Karolinska Development - First quarter results conference call Thursday, May 26
2011-05-18 08:01:00 Sweden Karolinska Development AB (publ) Stabilization announcement - Karolinska Development AB share Stabilization announcement - Karolinska Development AB share
2011-05-12 09:00:00 Sweden Karolinska Development AB (publ) Pergamum implements offset share issue worth SEK 120m Pergamum implements offset share issue worth SEK 120m
2011-05-11 07:31:00 Sweden Karolinska Development AB (publ) Axelar secures funding for the coming Phase II program in lung cancer Axelar secures funding for the coming Phase II program in lung cancer
2011-04-29 08:01:00 Sweden Karolinska Development AB (publ) Increased number of shares and votes in Karolinska Development Increased number of shares and votes in Karolinska Development
2011-04-19 15:36:00 Sweden Karolinska Development AB (publ) Notice of Annual General Meeting of Karolinska Development AB (publ) Notice of Annual General Meeting of Karolinska Development AB (publ)
2011-04-15 17:26:00 Sweden Karolinska Development AB (publ) Karolinska Development's Annual Report 2010 published Karolinska Development's Annual Report 2010 published
2011-04-13 13:32:00 Sweden Karolinska Development AB (publ) Karolinska Development invests in BioChromix Karolinska Development invests in BioChromix
2011-04-13 08:15:00 Sweden Karolinska Development AB (publ) Umecrine Mood receives financing for continued clinical development and strengthens the Board Umecrine Mood receives financing for continued clinical development and strengthens the Board
2011-04-06 18:43:00 Sweden Karolinska Development AB (publ) NeoDynamics' innovative cancer treatment featured in Swedish science television program "Vetenskapens Värld" NeoDynamics' innovative cancer treatment featured in Swedish science television program "Vetenskapens Värld"
2011-04-06 07:30:00 Sweden Karolinska Development AB (publ) Axelar announces positive interim results in Phase I/II study Axelar announces positive interim results in Phase I/II study
2011-03-31 08:55:00 Sweden Karolinska Development AB (publ) Promimic Named as One of Sweden's Hottest Technology Companies Promimic Named as One of Sweden's Hottest Technology Companies
2011-03-27 22:00:00 Sweden Karolinska Development AB (publ) Karolinska Development to be listed Karolinska Development to be listed
2011-02-25 09:00:00 Sweden Karolinska Development AB (publ) Karolinska Development AB (publ) Year-End Report, January - December 2010 Karolinska Development AB (publ) Year-End Report, January - December 2010
2011-02-23 07:01:00 Sweden Karolinska Development AB (publ) Aprea reports completion of the Phase I/II safety study with APR-246 in cancer patients Aprea reports completion of the Phase I/II safety study with APR-246 in cancer patients
2011-02-22 07:00:00 Sweden Karolinska Development AB (publ) Karolinska Development appoints Benjamin Nordin as Investor Relations Director Karolinska Development appoints Benjamin Nordin as Investor Relations Director
2011-02-14 07:00:00 Sweden Karolinska Development AB (publ) Pergamum to extend Phase II clinical trial for prevention of post-surgical adhesions Pergamum to extend Phase II clinical trial for prevention of post-surgical adhesions
2011-02-11 07:00:00 Sweden Karolinska Development AB (publ) Two innovations in Karolinska Development's portfolio selected in an international innovation initiative Two innovations in Karolinska Development's portfolio selected in an international innovation initiative
2011-02-10 08:10:00 Sweden Karolinska Development AB (publ) Karolinska Development appoints Terje Kalland as CSO Karolinska Development appoints Terje Kalland as CSO
1| 2|
Reklama

Spłacasz kredyt w walutach?

zobacz jak wiele możesz zaoszczędzić, obniżając wysoki spread.

Oszczędzaj na każdym przelewie nawet 1500 zł dla kwoty 10 000 euro bez wychodzenia z domu. więcej »

?
Zacznij wprowadzać nazwę interesującego Cie waloru
Giełda na skróty
SPÓŁKI GPW
  • Popularne
    na forum
  • Ostatnio
    oglądane
  • Mój
    portfel
Walor Kurs Zm.[%] Obrót
[mln]
PETROLINV 1,18 -4,07 5,03
VICTORIA 0,04 +0,00 0,00
ANTI 0,69 -1,43 0,02
ANALIZATOR Znajdź SPÓŁKĘ
WIĘCEJ KRYTERIÓW
?
Wprowadź listę symboli lub nazw walorów, które chcesz porównać na wykresie, rozdzielając je przecinkami.

W trakcie wypełniania pola, system będzie podpowiadał nazwy dostępnych walorów - możesz wybrać je z utworzonej listy.
Money analytics
money analytics